Regression of left ventricular hypertrophy in human hypertension with irbesartan.

@article{Malmqvist2001RegressionOL,
  title={Regression of left ventricular hypertrophy in human hypertension with irbesartan.},
  author={Karin Malmqvist and Thomas Kahan and Magnus Edner and Claes Held and Anders H{\"a}gg and Lars Lind and Richard M{\"u}ller-Brunotte and Fredrik Nystr{\"o}m and Karl Peter Ohman and Mary D. Osbakken and J Ostergern},
  journal={Journal of hypertension},
  year={2001},
  volume={19 6},
  pages={1167-76}
}
BACKGROUND The Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA). OBJECTIVE Angiotensin II induces myocardial hypertrophy. We hypothesized that blockade of angiotensin II subtype 1 (AT1) receptors by the AT1-receptor antagonist irbesartan would reduce left ventricular mass (as measured by echocardiography) more than conventional treatment with a beta blocker. DESIGN AND METHODS This double-blind study randomized 115 hypertensive men and women with left… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 51 extracted citations

Similar Papers

Loading similar papers…